GLP1s, Muscle Loss and the Moment Canada Can’t Miss

GLP-1s, Muscle Loss and the Moment Canada Can’t Miss
Picture of By Erin Phelan

By Erin Phelan

Fitness Industry Council of Canada

GLP-1 medications are reshaping the conversation around obesity in Canada—and around the world.

 

Today, that conversation took a significant step forward.

 

A global coalition including the World Obesity Federation, the Health & Fitness Association, AUSactive, Exercise New Zealand, ukactive, and the Fitness Industry Council of Canada released a joint position statement calling for physical activity and nutrition to be embedded into the rollout of obesity medications.

 

The message is clear: GLP-1s are powerful – but they are incomplete without movement, nutrition and support.

 

This is not a fringe issue. It is a systems issue.

 

Canada is facing a significant and growing obesity challenge. Recent national data shows that roughly two-thirds of adults are living with overweight or obesity, with obesity continuing to rise. This is closely tied to increased risk of cardiovascular disease, type 2 diabetes, musculoskeletal conditions and reduced quality of life.

 

At the same time, the use of GLP-1 medications is accelerating. Drugs like semaglutide and tirzepatide are now firmly part of the treatment landscape. For many individuals, they represent a meaningful and necessary clinical tool.

 

But they are not a complete solution.

 

The joint position statement released today emphasizes that obesity is a complex, chronic disease – one that cannot be addressed through pharmacology alone. It calls for integrated models of care that include access to physical activity, nutrition support and behaviour change alongside medication. It also warns of the risks of relying on medication in isolation, including poor long-term outcomes, loss of muscle mass and widening health inequalities if supportive services are not accessible.

 

This is where the Canadian conversation needs to evolve.

 

If we are going to talk about GLP-1s, we also need to shift how we talk about obesity itself. On World Obesity Day, Obesity Canada’s Executive Director Lisa Schaffer challenged the persistent narrative that obesity is simply a matter of individual responsibility. She described a system where people are navigating environments and care models that were never designed with them in mind – and where stigma is still too often disguised as advice.

 

That perspective matters. Because if we continue to frame obesity as a personal failure, we will continue to design incomplete solutions.

 

Obesity Canada has also been clear in its clinical guidance: weight is not a behaviour, and it should not be the sole measure of success. Health, function, quality of life and long-term outcomes matter more.

 

And this is where the GLP-1 conversation becomes more complex and more urgent.

 

One of the most under-discussed realities of GLP-1 use is the risk of muscle loss.

 

Emerging research shows that a meaningful portion of weight lost on these medications comes from lean mass. In some cases, that number is substantial. While not all lean mass is muscle, the implications are clear. Without intervention, individuals—particularly older adults – may lose strength, functional capacity and metabolic resilience alongside body weight.

 

That is not a side effect. That is a defining issue—and a red flag for our healthcare system.

 

Muscle is foundational to how we move, how we age, and how we maintain independence. Loss of muscle mass is linked to increased risk of falls, frailty, and long-term health decline. In a country with an aging population, this is not acceptable collateral damage. It must sit at the centre of how we evaluate treatment, define success, and design care.

 

And yet, much of the public narrative still focuses on how quickly weight can be lost, not what is being lost in the process.

 

The global statement released today brings that issue into focus.

 

Health & Fitness Association President and CEO Liz Clark underscored that physical activity and nutrition are not optional add-ons—they are foundational to safety, effectiveness and long-term success.

 

“The emergence of effective obesity medications marks a pivotal moment in global health, but it also presents a critical choice. We can treat obesity as a short-term clinical intervention, or we can build systems that deliver lasting health outcomes,” said Clark. “Physical activity and nutrition are not optional add-ons; they are foundational to safety, effectiveness, and long-term success. This is an opportunity to properly position our sector as an essential partner in prevention and care while ensuring individuals retain the freedom to engage in physical activity in the environments where they feel most comfortable.”

Fitness Industry Council of Canada Executive Director Zach Weston reinforced that point, noting that as these medications become more widely used, we must ensure individuals are not just losing weight, but maintaining the muscle mass and functional capacity that support long-term health.

 

“As we navigate this new era of clinical obesity treatments, we must recognize that medication is only one piece of the puzzle. For these therapies to deliver true, sustainable health outcomes, they must be anchored by the professional guidance and supportive environments found in our fitness centres,” says Weston.

 

“Our facilities are more than just places to exercise; they are essential community hubs for maintaining the muscle mass and functional capacity that are often at risk during rapid weight loss. By integrating fitness infrastructure into the global rollout of these medications, we ensure that patients aren’t just losing weight but are gaining the strength and long-term vitality necessary for a healthier life.”

 

This points to something the Canadian system has not fully addressed yet: integration.

 

Right now, access to GLP-1 medications in Canada is inconsistent. Coverage varies across provinces and insurance plans. At the same time, access to structured exercise support, qualified professionals and community-based fitness environments is also uneven.

 

We are at risk of building a system where medication is scaled, but support is not.

 

For the fitness industry, this moment requires clarity.

 

This is not about reacting to a trend. It is about stepping into a defined role within the health system.

 

Fitness facilities are not just places to exercise. They are environments where people rebuild strength, regain confidence and reconnect with their bodies. They are where muscle is preserved, where function is restored and where long-term habits are formed.

 

That matters more now than ever.

 

If GLP-1s are going to deliver on their promise, they must be paired with resistance training, adequate nutrition and ongoing support. Without that, we risk trading one set of health challenges for another.

 

The joint position statement released today is not simply a recommendation.

 

It is a call to action – for governments around the world, for health systems and for our industry.

 

Canada does not need a louder conversation about weight loss.

 

It needs a smarter, more integrated conversation about health.

 

And this is the moment to get that right.

Fitness Industry Council of Canada (FIC) is the not-for profit trade association that represents the voice of fitness facility operators across Canada. Representing more than 6,000 facilities with more than six-million members nationwide, FIC pursues a legislative agenda in the hope of bettering the fitness industry for both consumers and operators. FIC aims to work with both industry and government to improve the health and physical activity levels of Canadians.

Stay Connected!

Subscribe to FitBizWeekly’s FREE newsletter for news, commentary, idea sharing and developments across the Canadian health and fitness industry.


By clicking on the Subscribe button you agree to be on our newsletter list. You can opt out anytime. We respect your privacy. Your information will not be shared and your email address will be stored safely. 

STAY TUNED

subscribe to our weekly newsletter